Operative time and intraoperative blood loss were similar between the groups.<h4>Conclusion</h4>In patients with high-risk prostate cancer, undergoing NHT for longer than 3 months was associated with greater suppression of PSA and more favorable pathological outcomes. The gene discussed is KLK3; the disease is Familial prostate cancer.